Literature DB >> 36155839

CALR loss-of-heterozygosity as a potential driver for extramedullary AML.

Marie-Christine Weller1, Eugenia Haralambieva2,3, Marco Matteo Bühler2, Rudolf Benz4, Alexandre Pierre André Theocharides1, Stefan Balabanov5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 36155839     DOI： 10.1007/s00277-022-04976-8

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   4.030


× No keyword cloud information.
  1 in total

1.  Calreticulin haploinsufficiency augments stem cell activity and is required for onset of myeloproliferative neoplasms in mice.

Authors:  Kotaro Shide; Takuro Kameda; Ayako Kamiunten; Yoshinori Ozono; Yuki Tahira; Takako Yokomizo-Nakano; Sho Kubota; Masaya Ono; Kazuhiko Ikeda; Masaaki Sekine; Keiichi Akizuki; Kenichi Nakamura; Tomonori Hidaka; Yoko Kubuki; Hisayoshi Iwakiri; Satoru Hasuike; Kenji Nagata; Goro Sashida; Kazuya Shimoda
Journal:  Blood       Date:  2020-07-02       Impact factor: 22.113
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.